Comprehensive cardiovascular disease risk assessment across European and US-based longitudinal populations by integrating polygenic risk scores

被引：0

作者：

Sedaghati-khayat, Bahar ^{[1
]}

Tan, Jingyi ^{[2
]}

Yao, Jie ^{[2
]}

Mazumdar, Tapati ^{[2
]}

Bos, Maxime ^{[3
]}

Cerniglia, Katherine ^{[2
]}

Broer, Linda ^{[1
]}

Taylor, Kent D. ^{[2
]}

Li, Xiaohui ^{[2
]}

Van Meurs, Joyce ^{[1
]}

Ikram, Arfan ^{[3
]}

Bartaria, Shubhi ^{[2
]}

Post, Wendy ^{[2
]}

Sincan, Murat ^{[2
]}

Uitterlinden, Andre ^{[1
]}

Guo, Xiuqing ^{[2
]}

Kavousi, Maryam ^{[3
]}

Hajek, Catherine ^{[2
]}

Lin, Henry J. ^{[2
]}

van rooij, Jeroen ^{[1
]}

Rotter, Jerome I. ^{[2
]}

机构：

[1] Erasmus MC, Internal Med, Rotterdam, Netherlands

[2] Lundquist Inst, Inst Translat Genom & Populat Sci, Dept Pediat, Torrance, CA USA

[3] Erasmus MC, Epidemiol, Rotterdam, Netherlands

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2024年 / 32卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P20.005.A

引用

页码：703 / 704

页数：2

共 50 条

[1] Clinical Implications of Integrating Polygenic Risk Into Established Cardiovascular Disease Risk Scores
Riveros-Mckay, Fernando
Selzam, Saskia
Seth, Priyanka
Moore, Rachel
Tarran, William A.
O'Sullivan, Jack W.
Ashley, Euan A.
McVean, Gilean
Plagnol, Vincent
Donnelly, Peter
Weale, Michael E.
[J]. CIRCULATION, 2021, 144
[2] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
Hadley, Trevor D.
Agha, Ali M.
Ballantyne, Christie M.
[J]. CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (06)
[3] Using Polygenic Risk Scores for Prioritizing Individuals at Greatest Need of a Cardiovascular Disease Risk Assessment
Chung, Ryan
Xu, Zhe
Arnold, Matthew
Ip, Samantha
Harrison, Hannah
Barrett, Jessica
Pennells, Lisa
Kim, Lois G.
Di Angelantonio, Emanuele
Paige, Ellie
Ritchie, Scott C.
Inouye, Michael
Usher-Smith, Juliet A.
Wood, Angela M.
[J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (15):
[4] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
Trevor D. Hadley
Ali M. Agha
Christie M. Ballantyne
[J]. Current Atherosclerosis Reports, 2021, 23
[5] Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program
Vassy, Jason L.
Posner, Daniel C.
Ho, Yuk-Lam
Gagnon, David R.
Galloway, Ashley
Tanukonda, Vidisha
Houghton, Serena C.
Madduri, Ravi K.
McMahon, Benjamin H.
Tsao, Philip S.
Damrauer, Scott M.
O'Donnell, Christopher J.
Assimes, Themistocles L.
Casas, Juan P.
Gaziano, J. Michael
Pencina, Michael J.
Sun, Yan V.
Cho, Kelly
Wilson, Peter W. F.
[J]. JAMA CARDIOLOGY, 2023, 8 (06) : 564 - 574
[6] Combining European and US risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study
de La Harpe, Roxane
Thorball, Christian W.
Redin, Claire
Fournier, Stephane
Mueller, Olivier
Strambo, Davide
Michel, Patrik
Vollenweider, Peter
Marques-Vidal, Pedro
Fellay, Jacques
Vaucher, Julien
[J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (07) : 561 - 571
[7] GENERALIZABILITY OF POLYGENIC RISK SCORES WITHIN AND ACROSS DIVERSE AFRICAN POPULATIONS
Majara, Lerato
Kalungi, Allan
Koen, Nastassja
Zar, Heather
Stein, Dan
Martin, Alicia
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S24 - S24
[8] Principles and methods for transferring polygenic risk scores across global populations
Kachuri, Linda
Chatterjee, Nilanjan
Hirbo, Jibril
Schaid, Daniel J.
Martin, Iman
Kullo, Iftikhar J.
Kenny, Eimear E.
Pasaniuc, Bogdan
Witte, John S.
Ge, Tian
Auer, Paul L.
Chatterjee, Nilanjan
Conomos, Matthew P.
Conti, David V.
Ding, Yi
Kachuri, Linda
Wang, Ying
Zhang, Haoyu
Zhang, Yuji
[J]. NATURE REVIEWS GENETICS, 2024, 25 (01) : 8 - 25
[9] Principles and methods for transferring polygenic risk scores across global populations
Linda Kachuri
Nilanjan Chatterjee
Jibril Hirbo
Daniel J. Schaid
Iman Martin
Iftikhar J. Kullo
Eimear E. Kenny
Bogdan Pasaniuc
John S. Witte
Tian Ge
[J]. Nature Reviews Genetics, 2024, 25 : 8 - 25
[10] Considerations for clinical implementation of polygenic risk scores in diverse US populations
[J]. Nature Medicine, 2024, 30 : 354 - 355

← 1 2 3 4 5 →